Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean aprd00034 of aprd00475?
Displaying all 2 drugs
Brimonidine is an alpha-adrenergic agonist and 2-imidazoline derivative that was first introduced in 1996. It is considered to be a third generation alpha-2 aadrenergic receptor agonist, since it displays preferential binding at alpha-2 adrenoceptors over alpha-1 receptors. Brimonidine displays a higher selectivity toward the alpha-2 adrenergic receptors than clonidine or...
Approved
Matched Description: … Brimonidine displays a higher selectivity toward the alpha-2 adrenergic receptors than [clonidine] or ... [A178945] Thus brimonidine is an effective and safe alternative to beta-blockers, in patients with, or
Brinzolamide is a highly specific, non-competitive, reversible carbonic anhydrase II (CA-II) inhibitor indicated to reduce ocular pressure in patients with ocular hypertension or open-angle glaucoma. Although the exact pathophysiology of glaucoma is still unknown, one of the main hallmarks of this disease is vascular dysregulation and abnormalities.[A2049,A2051] The resulting vascular...
Approved
Matched Description: … anhydrase II (CA-II) inhibitor indicated to reduce ocular pressure in patients with ocular hypertension or
Displaying all 2 drugs